Next Article in Journal
A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer
Next Article in Special Issue
Combination of Chemotherapy and Mild Hyperthermia Using Targeted Nanoparticles: A Potential Treatment Modality for Breast Cancer
Previous Article in Journal
Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans
Previous Article in Special Issue
Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(3), 943; https://doi.org/10.3390/pharmaceutics15030943
Action Date Notes Link
article html file updated 5 September 2025 18:16 CEST Update https://www.mdpi.com/1999-4923/15/3/943/html
article html file updated 20 March 2023 23:15 CET Update -
article html file updated 14 March 2023 13:58 CET Original file -
article supplementary file uploaded. 14 March 2023 13:57 CET - https://www.mdpi.com/1999-4923/15/3/943#supplementary
article pdf uploaded. 14 March 2023 13:57 CET Version of Record https://www.mdpi.com/1999-4923/15/3/943/pdf
article xml uploaded. 14 March 2023 13:57 CET Update https://www.mdpi.com/1999-4923/15/3/943/xml
article xml file uploaded 14 March 2023 13:57 CET Original file -
Back to TopTop